Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 4/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6904198 | 0.91 | AHCY (0.33) | AHCY | |
| SCHEMBL6902586 | 0.84 | HPRT1 (0.43) | AHCY | |
| SCHEMBL6902812 | 0.83 | FGFR1 (0.39) | AHCY | |
| SCHEMBL6691656 | 0.75 | AHCY (0.36) | AHCYADORA2A | |
| SCHEMBL29782858 | 0.73 | FDPS (0.47) | AHCYADORA2A | |
| SCHEMBL6693460 | 0.73 | AHCY (0.37) | AHCYADORA2A | |
| SCHEMBL6903378 | 0.70 | CYP1A2 (0.51) | — | |
| SCHEMBL6693825 | 0.69 | AHCY (0.34) | AHCYADORA2A | |
| SCHEMBL6905054 | 0.68 | HPRT1 (0.45) | — | |
| SCHEMBL5080086 | 0.67 | ADORA2A (0.59) | AHCYADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040014722-A1 | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases | BIOCRYST PHARMACEUTICALS, INC. | 2004-01-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014722-A1 | Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases | NSUN2, POLR2H, NSUN3 | AHCY 921/4885ADORA2A 2690/4885CDK5 2669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.